Renowned investor Cathie Wood, chief executive of Ark Investment Management, on Tuesday continued her recent patterns, buying biotechnology stocks, a spectrometry stock, a 3D printer maker and a robotics-software stock.
She also sold a financial technology stock. (All the valuations below are as of Tuesday’s close.)
បដិវត្តពន្ធុវិទ្យាអេធី។ អេហ្វ (អេខេខេជី) - ទទួលបានរបាយការណ៍ ARK Genomic Revolution ETF purchased 119,876 shares of biotech company Personalis (PSNL) - Get Personalis, Inc. Reportដែលមានតម្លៃ 890,679 ដុល្លារ។
Source: https://www.thestreet.com/investing/cathie-wood-ark-spectrometry-biotech-stocks?puc=yahoo&cm_ven=YAHOO&yptr=yahoo